Drug screening among patients aged 17-40 admitted with psychosis;Rusmiddelscreening av pasienter i alderen 17-40 år innlagt med psykose

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 9, 2005, Pages 1178-1180

  Helseth, Valborg ^a   Lykke Enger, Tone ^a   Aamo, Trond Oskar ^b   Johnsen, Jon ^a  

^a VESTRE VIKEN HOSPITAL TRUST   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; ILLICIT DRUG; METHADONE; OPIATE; ZOPICLONE;

ADOLESCENT; ADULT; ARTICLE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG SCREENING; DRUG URINE LEVEL; FEMALE; HUMAN; INTERVIEW; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; NORWAY; PSYCHOSIS; RELIABILITY; SCORING SYSTEM; SELF REPORT; SUBSTANCE ABUSE; COMPARATIVE STUDY; DRINKING BEHAVIOR; HOSPITAL ADMISSION; QUESTIONNAIRE;

ADOLESCENT; ADULT; ALCOHOL DRINKING; FEMALE; HUMANS; MALE; PATIENT ADMISSION; PSYCHOSES, SUBSTANCE-INDUCED; QUESTIONNAIRES; SUBSTANCE ABUSE DETECTION;

EID: 18744366959     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiological catchment area (ECA) study. JAMA 1990; 264: 2511-8.
2. Wittchen HU, Perkonigg A, Reed V. Comorbidity of mental disorders and substance use disorders. Eur Addict Res 1996; 2: 36-47.
3. Weaver T, Madden P, Charles V et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003; 183: 304-13.
4. Phillips P, Johnson S. Drug and alcohol misuse among in-patients with psychotic illnesses in three inner-London psychiatric units. Psychiatr Bull 2003; 27: 217-20.
5. Cantor-Graae E, Nordstrøm LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 2001; 48: 69-82.
6. Gråwe RW, Pedersen PB, Widén JH. Changes in prevalence and comorbidity in a total population of patients with psychotic disorders in Norwegian psychiatric hospitals. Nord J Psychiatry 1997; 51: 127-32.
7. Personer med samtidig alvorlig psykisk lidelse og omfattende rusmisbruk. IK- 2727. Oslo: Statens helsetilsyn, 2000.
8. Møller T, Linaker OM. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse. Nord J Psychiatry 2004; 58: 237-42.
9. Landheim AS, Bakken K, Vaglum P. Sammensatte problemer og separate systemer: psykiske lidelser blant rusmisbrukere til behandling i russektoren. Nor J Epidemiol 2002; 12: 309-18.
10. Zahlsen K, Aamo T, Zweigenbaum J. Screening drugs of abuse by LC/MS Technical overview. Agilent Technologies, August 23, 2004. Publication 5989-1541 EN. www.agilent.com/chem
11. Kokkevi A, Hartgers C. European Addiction Severity Index EuropASI. Zürich: EuropASI Working Group, CostA6, 1994.
12. Fowler IL, Carr VJ, Carter NT et al. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24: 443-55.
13. Claassen CA, Gilfillan S, Orsulak P et al. Substance use among patients with a psychotic disorder in a psychiatric emergency room. Psychiatr Serv 1997; 48: 353-8.
14. Schiller MJ, Shumway M, Batki SL. Utility of routine drug screening in a psychiatric emergency setting. Psychiatr Serv 2000; 51: 474-8
15. Modestin J, Nussbaumer C, Angst K et al. Use of potentially abusive psychotropic substances in psychiatric inpatients. Eur Arch Psychiatry Clin Neurosci 1997; 247: 146-53.
16. Perrone J, de Roos F, Jayaraman S et al. Drug screening versus history in detection of substance use in ED psychiatric patients. Am J Emerg Med 2001; 19: 49-51.